Related Experiment Video

Updated: Aug 10, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

The management of cryptococcal meningitis in Papua New Guinea

R A Seaton1

  • 1Department of Clinical Sciences, University of Papua New Guinea, Port Moresby, Papua New Guinea.

Papua and New Guinea Medical Journal
|March 1, 1996
PubMed

Insights

Cryptococcal meningitis treatment requires careful monitoring for adverse effects. Combination therapy with amphotericin B and flucytosine is the current best practice, though ancillary treatments may be needed.

Area of Science:

  • Infectious Diseases
  • Neuroscience
  • Pharmacology

Background:

  • Cryptococcal meningitis presents significant treatment challenges.
  • Effective management necessitates monitoring for treatment-related adverse events.
  • Standard therapies often have high case fatality and morbidity rates.

Purpose of the Study:

  • To review the current treatment strategies for cryptococcal meningitis.
  • To highlight the importance of biochemical and haematological monitoring.
  • To discuss potential ancillary treatments for complex cases.

Main Methods:

  • Review of current clinical guidelines and treatment protocols.
  • Analysis of established combination therapy regimens.
  • Consideration of emerging therapeutic options and supportive care.

Main Results:

  • Combination therapy with amphotericin B and flucytosine for a minimum of 6 weeks is the most effective evaluated treatment.
  • The role of azole antifungals requires further investigation through large multicentre studies.
  • Ancillary treatments, including corticosteroids and interventions for intracranial pressure, may be necessary.

Conclusions:

  • Optimal cryptococcal meningitis management involves combination therapy and vigilant monitoring.
  • Further research is needed to clarify the utility of azole drugs.
  • Individualized patient care incorporating supportive measures is crucial for improving outcomes.

More Related Videos

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans08:24

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Published on: February 27, 2018

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...